A newly documented outbreak of locally acquired malaria in the US is renewing concerns about whether clinical laboratories are adequately prepared to identify infectious diseases many healthcare organizations rarely encounter anymore.
The Centers for Disease Control and Prevention reported that 10 people across Arkansas, Florida, Maryland, and Texas contracted mosquito-transmitted malaria during 2023 despite having no recent travel history. The cases marked the first known local malaria transmission events reported in the US in approximately 20 years.
For laboratory professionals, the outbreak serves as a reminder that diseases once considered largely imported by travelers can still create diagnostic and operational challenges for hospitals and public health systems.
Most malaria cases diagnosed in the US are tied to international travel. Roughly 2,000 infections are reported nationally each year, but nearly all originate outside the country. In the 2023 outbreak, however, health officials believe infected travelers were bitten by domestic mosquitoes, allowing transmission to spread locally to additional patients.
Although unrelated, the malaria cases and the recent outbreak of hantavirus on a cruise ship carry similar imperatives for clinical lab professionals. Catching these infections on a blood assay or flagging them for rapid molecular testing requires an elevated level of suspicion and heightened diagnostic vigilance.
Misdiagnosis concerns renew focus on laboratory readiness
The CDC warned that some malaria infections may initially have been overlooked or mistaken for other illnesses.
That concern carries important implications for clinical laboratories because malaria parasites can closely resemble babesiosis on blood smears. Babesiosis, which is endemic in parts of the US, shares many of the same symptoms, including fever, chills, headache, nausea, and body aches.
For laboratorians with limited recent experience identifying malaria microscopically, distinguishing between the two diseases may prove difficult without confirmatory molecular testing.
CDC is encouraging healthcare providers and laboratories to consider malaria even in patients without travel exposure during outbreak investigations. The agency also recommended polymerase chain reaction (PCR) testing to help confirm suspected cases and reduce the risk of misdiagnosis.
Beyond the immediate outbreak, the situation raises broader preparedness questions for laboratory leaders.
Many hospital laboratories no longer routinely encounter tropical parasitic diseases, yet factors such as increased global travel, climate shifts, and expanding mosquito habitats may increase the likelihood of future localized transmission events involving vectorborne diseases.
The outbreak also highlights the continued importance of maintaining competency in parasitology, microscopy review, reflex molecular testing workflows, and communication with public health agencies.
For laboratories already facing staffing shortages and growing testing complexity, the CDC report underscores how emerging infectious disease threats can quickly place pressure on diagnostic systems that may not regularly handle rare pathogens.
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
